{"entity":{"type":"insider","cik":"0001278675","url":"/insider/0001278675","json_url":"/insider/0001278675.json","name":"HILL MATTHEW C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":6,"first":"2008-05-28","last":"2025-03-03","span_basis":"filed_date"},"name_variants":[{"name":"HILL MATTHEW C","source":"filing","n_filings":6,"first_seen":"2008-05-28","last_seen":"2025-03-03"}],"transactions":[{"id":9290335,"accession":"0001493152-25-008863","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-008863","line_url":"/filing/0001493152-25-008863#line-1","is_derivative":false,"issuer_cik":"0000719135","issuer_name":"Apyx Medical Corp","issuer_ticker":"APYX","issuer_name_source":null,"issuer_url":"/issuer/0000719135","owner_cik":"0001278675","owner_name":"HILL MATTHEW C","owner_display_name":"HILL MATTHEW C","owner_url":"/insider/0001278675","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":1.13,"price_display":"1.13","price_state":"stated","total_value":6780.0,"total_display":"6,780.00","total_whole":"6,780","shares_owned_after":8500.0,"shares_owned_after_display":"8,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2025-03-03","scope":"insider"},{"id":2425322,"accession":"0001493152-24-031725","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-031725","line_url":"/filing/0001493152-24-031725#line-1","is_derivative":false,"issuer_cik":"0000719135","issuer_name":"Apyx Medical Corp","issuer_ticker":"APYX","issuer_name_source":null,"issuer_url":"/issuer/0000719135","owner_cik":"0001278675","owner_name":"HILL MATTHEW C","owner_display_name":"HILL MATTHEW C","owner_url":"/insider/0001278675","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5336.0,"shares_display":"5,336","price_per_share":1.13,"price_display":"1.13","price_state":"stated","total_value":6029.68,"total_display":"6,029.68","total_whole":"6,030","shares_owned_after":7836.0,"shares_owned_after_display":"7,836","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-13","scope":"insider"},{"id":7812865,"accession":"0001493152-23-044805","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-044805","line_url":"/filing/0001493152-23-044805#line-1","is_derivative":false,"issuer_cik":"0000719135","issuer_name":"Apyx Medical Corp","issuer_ticker":"APYX","issuer_name_source":null,"issuer_url":"/issuer/0000719135","owner_cik":"0001278675","owner_name":"HILL MATTHEW C","owner_display_name":"HILL MATTHEW C","owner_url":"/insider/0001278675","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":2.19,"price_display":"2.19","price_state":"stated","total_value":5475.0,"total_display":"5,475.00","total_whole":"5,475","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-12","filed_date":"2023-12-14","scope":"insider"},{"id":5063145,"accession":"0001140361-21-041473","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-21-041473","line_url":"/filing/0001140361-21-041473","is_derivative":false,"issuer_cik":"0001278675","issuer_name":"PDS Biotechnology Corp","issuer_ticker":"PDSB","issuer_name_source":null,"issuer_url":"/issuer/0001278675","owner_cik":"0001278675","owner_name":"HILL MATTHEW C","owner_display_name":"HILL MATTHEW C","owner_url":"/insider/0001278675","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3100.0,"shares_display":"3,100","price_per_share":8.987096774193548,"price_display":"8.99","price_state":"stated","total_value":27860.0,"total_display":"27,860.00","total_whole":"27,860","shares_owned_after":3475.0,"shares_owned_after_display":"3,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2021-12-14","scope":"insider","n_lines":4},{"id":6749117,"accession":"0001140361-18-028569","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-18-028569","line_url":"/filing/0001140361-18-028569","is_derivative":false,"issuer_cik":"0001051514","issuer_name":"STRATA Skin Sciences, Inc.","issuer_ticker":"SSKN","issuer_name_source":null,"issuer_url":"/issuer/0001051514","owner_cik":"0001278675","owner_name":"HILL MATTHEW C","owner_display_name":"HILL MATTHEW C","owner_url":"/insider/0001278675","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"SSKN Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.961834,"price_display":"1.96","price_state":"stated","total_value":19618.34,"total_display":"19,618.34","total_whole":"19,618","shares_owned_after":8188.0,"shares_owned_after_display":"8,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-14","filed_date":"2018-06-14","scope":"insider","n_lines":3},{"id":3632911,"accession":"0001179110-08-010737","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-08-010737","line_url":"/filing/0001179110-08-010737#line-1","is_derivative":false,"issuer_cik":"0001278675","issuer_name":"VELCERA, INC.","issuer_ticker":"VLCR","issuer_name_source":null,"issuer_url":"/issuer/0001278675","owner_cik":"0001278675","owner_name":"HILL MATTHEW C","owner_display_name":"HILL MATTHEW C","owner_url":"/insider/0001278675","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000.0,"shares_display":"9,000","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":3600.0,"total_display":"3,600.00","total_whole":"3,600","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-28","filed_date":"2008-05-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000719135","name":"Apyx Medical Corp","url":"/issuer/0000719135","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2023-12-14","last_seen":"2025-03-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001472091","name":"PDS Biotechnology Corp","url":"/issuer/0001472091","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2021-12-14","last_seen":"2021-12-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001051514","name":"STRATA Skin Sciences, Inc.","url":"/issuer/0001051514","role":"Officer (CFO)","n_filings":1,"first_seen":"2018-06-14","last_seen":"2018-06-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001344300","name":"VELCERA, INC.","url":"/issuer/0001344300","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2008-05-28","last_seen":"2008-05-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001278675","retrieved_at":"2026-08-25T16:55:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}